Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • eTheRNA

    - PMLiVE

    Global Healthy Living Foundation and Medscape Education Join Forces to Bridge the Gap Between Patients and Providers with Immunology Education

    UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...

    Medscape Education

    - PMLiVE

    Almirall and Absci expand AI dermatological drug discovery partnership

    The alliance has already led to the delivery of functional antibody leads against a difficult-to-drug target

    - PMLiVE

    Apogee Therapeutics’ atopic dermatitis candidate shows promise in phase 2 study

    The inflammatory skin condition affects over 26 million people in the US

    - PMLiVE

    Honoring the Legacy of Dr. Robert Sidbury, MD, MPH

    We are deeply saddened by the recent passing of Dr. Robert Sidbury. Dr. Sidbury was a visionary in pediatric dermatology whose dedication to advancing patient care inspired clinicians, researchers, and...

    Medscape Education

    - PMLiVE

    LEO Pharma gains access to Boehringer’s skin disease drug for €90m upfront

    Spevigo is already approved in over 40 countries to treat generalised pustular psoriasis

    - PMLiVE

    Dermaliq and DEBRA partner to advance epidermolysis bullosa drug delivery

    Approximately 500,000 people worldwide are affected by the rare genetic skin disorders

    - PMLiVE

    LEO Pharma and the Parker Institute join forces to advance dermatology research

    The alliance will aim to discover molecules that could be incorporated into wider pharmaceutical research

    - PMLiVE

    LEO and Reig Jofre partner to improve access to psoriasis therapy in Europe

    Approximately 125 million people worldwide are affected by some form of the inflammatory condition

    - PMLiVE

    Almirall hosts Skin Academy to advance skin science and dermatology treatments

    The conference will cover actinic keratosis, psoriasis, atopic dermatitis and other skin diseases

    - PMLiVE

    LEO and DEBRA Research partner to advance epidermolysis bullosa treatments

    There is currently no cure for the group of rare inherited skin disorders

    - PMLiVE

    LEO Pharma’s Anzupgo cream granted MHRA approval to treat chronic hand eczema

    Anzupgo is the first topical pan-JAK inhibitor approved specifically for adults with moderate-to-severe cases

    - PMLiVE

    FDA approves Journey Medical’s Emrosi to treat inflammatory lesions of rosacea

    The long-term skin condition affects more than 16 million people in the US

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links